These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2832680)

  • 1. Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.
    Houlihan WJ; Lee ML; Munder PG; Nemecek GM; Handley DA; Winslow CM; Happy J; Jaeggi C
    Lipids; 1987 Nov; 22(11):884-90. PubMed ID: 2832680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of a piperidine phospholipid.
    Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW
    Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C; Watson JV; Workman P
    Cancer Res; 1991 Feb; 51(3):799-806. PubMed ID: 1988120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
    Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
    J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells.
    Workman P; Donaldson J; Lohmeyer M
    Biochem Pharmacol; 1991 Jan; 41(2):319-22. PubMed ID: 1989642
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
    Storch J; Munder PG
    Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of enantio-selectivity in the in vitro antitumour cytotoxicity and membrane-damaging activity of ether lipid SRI 62-834: further evidence for a non-receptor-mediated mechanism of action.
    Lohmeyer M; Workman P
    Biochem Pharmacol; 1992 Aug; 44(4):819-23. PubMed ID: 1510728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
    Civoli F; Daniel LW
    Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
    Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
    Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of synthetic alkylphospholipids with or without PAF activity.
    Kudo I; Nojima S; Chang HW; Yanoshita R; Hayashi H; Kondo E; Nomura H; Inoue K
    Lipids; 1987 Nov; 22(11):862-7. PubMed ID: 3444379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.
    Leder GH; Fiebig HH; Wallbrecher E; Winterhalter BR; Löhr GW
    Lipids; 1987 Nov; 22(11):958-61. PubMed ID: 3444393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells.
    Kosano H; Takatani O
    J Lipid Mediat; 1990; 2(2):117-21. PubMed ID: 2135668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
    Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
    Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
    Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
    Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
    Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplastic cell inhibition with new ether lipid analogs.
    Noseda A; Berens ME; Piantadosi C; Modest EJ
    Lipids; 1987 Nov; 22(11):878-83. PubMed ID: 3444381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of cell signaling pathways by antitumor ether lipids.
    Arthur G; Bittman R
    Biochim Biophys Acta; 1998 Feb; 1390(1):85-102. PubMed ID: 9487143
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
    Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R
    Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
    Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
    Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.